NCT07579845NARecruitingAccepts Healthy Volunteers
Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress
OvationLab
Start Date
5/5/2026
Completion Date
9/1/2026
Summary
The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.
Eligibility Criteria
Age Range: 40 years to No maximum
Inclusion Criteria:
1. Adult females or males age ≥ 40 years
2. Ability to read and speak English
Exclusion Criteria:
1. Current use of a dietary supplement containing fulvic or humic acid
2. Current use of other binder dietary supplements, including activated charcoal, modified citrus pectin, bentonite clay, or chlorella
3. Known allergies to any ingredients in the product
4. Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks
5. Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol
6. Participants unable to provide consent
Interventions
DIETARY_SUPPLEMENT
Humic and Fulvic Acid Dietary Supplement
Conditions
DetoxificationInflammationBiological Aging
Locations
OvationLab
Richmond, Virginia 23220
United States